Pfizer-OPKO's Growth Hormone Drug Gets US Approval in Kids
The FDA has approved Pfizer Inc and partner OPKO Health's treatment for growth hormone deficiency in children, the companies said on Wednesday.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/993794?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/993794?src=rss
Comments
Post a Comment